NEW YORK, April 25, 2018 /PRNewswire/ --
According to a report by Oristep Consulting, the global medical cannabis market in 2016 was valued at $12.67 billion and is projected to reach $33.41 billion by 2022 at a CAGR of
17.53% during the forecast period. Various scientific studies of the chemical called cannabinoid have already resulted in two
FDA-approved medications in a pill form. The two main cannabinoids from the cannabis plant are THC and CBD, which are used for
medical purposes as treatments for various conditions such as increasing appetite, reduce nausea, decreasing pain, inflammation,
and muscle control problems. The report also indicates that North America leads the market
holding nearly half of the market share in 2016. WeedMD Inc. (OTC: WDDMF), Organigram Holdings Inc. (OTC: OGRMF), Supreme
Cannabis Company, Inc. (OTC: SPRWF), THC BioMed Intl Ltd. (OTC: THCBF), iAnthus Capital Holdings, Inc. (OTC: ITHUF)
Earlier this year California has started legal sales of recreational cannabis. While sales
are growing, there are concerns that supply will fall short of demand. According to a report by the Chicago Tribune, Charles Boldwyn, chief compliance officer of ShowGrow in Santa Ana,
explained, "We're looking at … hundreds of licensed cultivators and manufacturers coming out of an environment where we literally
had thousands of people who were cultivating and manufacturing… So the red tape is a bit of a bottleneck in the supply chain."
Despite the concerns, the market in California is expected to witness strong growth. The state
Department of Finance expects Californians to purchase about 1 million pounds of cannabis over the first full year of
legalization, between July 1, 2018, and June 30, 2019.
WeedMD Inc. (OTC: WDDMF) is also listed on the TSX Venture Exchange under the ticker symbol (TSX-V: WMD). Last
week the company announced breaking news together with Hiku Brands Company Ltd. (CSE: HIKU) that, "they have entered into a
definitive agreement (the "Arrangement Agreement") to merge both companies, creating an industry leader (the "Transaction"). The
Transaction combines two highly-complementary businesses and creates a unique and market differentiating vertically integrated
company. Upon completion of the Transaction, existing Hiku and WeedMD shareholders will own approximately 51.75% and 48.25% of
the combined company, respectively, on a fully-diluted basis. Upon closing of the Transaction, it is anticipated that the common
shares of the pro forma resulting entity will be listed on the TSX Venture Exchange ("TSX-V"), subject to regulatory approvals.
Joint management will be hosting a conference call on Friday, April 20, 2018 beginning at 10:00AM EST. See end of
the press release for details.
The combination of Hiku and WeedMD creates a premium cannabis brand house with fully vertically integrated operations, an
expanding network of retail stores, a growing medical business and four scalable cannabis production facilities, two of which are
currently licensed. As a result of the Transaction, Hiku will operate a diverse cannabis supply chain that includes a large
portfolio of unique genetics for its growing brand portfolio and emerging nationwide retail sales channels. The entity combines
Hiku's strength in retail and branding - ensuring a high quality, consistent and educational consumer experience in the adult-use
cannabis market - with WeedMD's existing service and quality in the medical market.
"Our vision at Hiku has always been that cannabis is a consumer product - in which brands, retail and customer experience will
ultimately win," said Alan Gertner, Chief Executive Officer of Hiku. "The combination of Hiku and WeedMD creates a cannabis
company capable of fulfilling the vision of delivering the best in class experiences from in-store to product, from medical to
adult-use, but also capturing full retail and wholesale margins. Our combined offerings create a company that is insulated from
potential wholesale margin compression and is ready to scale its offering globally."
Bruce Dawson-Scully, Chief Executive Officer of WeedMD, said, "WeedMD was founded on the
principles of product and patients first. Our goal since inception has been on procuring world class genetics, cultivating
premium medical cannabis, and delivering it with best-in-class service to our valued patient base. We look forward to the next
step in WeedMD's journey by merging with Hiku, a complimentary group that furthers our mission by bringing our focus and passion
into a more robust platform. Having access to iconic brands and a growing retail footprint to execute on our growth plan together
with our cultivation and existing medical expertise is intended to ensure significant benefits to our shareholders and expected
to present significant upside as Canada marches towards legalization."
Hiku has built a portfolio of iconic, engaging cannabis brands, immersive retail experiences and handcrafted cannabis
production. Hiku is recognized as an early leader in Canada's emerging adult-use market, with the Tokyo Smoke retail
banner awarded Brand of the Year at the 2017 Lift Cannabis Awards. In February 2018, Tokyo Smoke, Hiku's wholly owned
subsidiary, was awarded one of only four conditional master licenses for cannabis retail in Manitoba, an important milestone
in Hiku's Canada-wide cannabis retail expansion plans.
With a retail footprint led by Tokyo Smoke, cannabis production through DOJA's ACMPR licensed facility, and Van der
Pop's female-focused educational platforms, Hiku houses an industry-leading portfolio for cannabis
in Canada's adult-use market. WeedMD operates a 26,000 square foot indoor facility with over 1,500 kg of current
production capacity and is fully funded for a large-scale production expansion of a 14-acre greenhouse on a 98-acre property
representing an increase to more than 50,000 kg of capacity. The combined companies create a brand-focused retail business with
the ability to provide product quality and selection on par with the retail experience itself.
Highlights of the Transaction:
- Vertically Integrated Operations Secure Control Over Entire Cannabis Value Chain: The combined entity will leverage Hiku's
growing retail operations as sales channels for premium cannabis supply, allowing for the realization of superior wholesale and
retail margins. The Transaction ensures Hiku's control over both upstream and downstream components of the cannabis value
chain
- Highly Complementary Strengths: The Transaction combines Hiku's portfolio of iconic brands, visionary marketing and
experiential retail stores with WeedMD's scalable cannabis production capabilities, deep genetics library, and innovative
research and development initiatives
- Visionary Leadership with Significant Experience: Experienced management team with leading capabilities in branding,
marketing, retail and cannabis production
- Dynamic Retail Growth Across Canada: The combined company plans to aggressively pursue the expansion of its existing
retail store network, including the addition of legal retail cannabis stores and online cannabis sales channels where permitted
in British Columbia, Alberta, Saskatchewan and Manitoba where Tokyo Smoke was conditionally
awarded one of four master licenses for retail cannabis sales
- Superior and Diversified Cannabis Cultivation: This combination brings together four indoor and greenhouse growing
facilities in Ontario and British Columbia, with the option for future expansion on more than 100 acres of
property at the existing sites. Current planned capacity will exceed 56,000 kg by mid-2019
- Extensive and Unique Genetics: Deep library of unique cannabis genetics is the basis for premium cannabis products in both
the adult-use and medical markets
- Enhanced Capital Markets Profile: Increased scale of the combined company will enhance its capital markets profile and
trading liquidity, in addition, the combined entity will be listed on TSX-V, subject to regulatory approvals
- Expanded Platform for Future Growth: Together, the combined company will have substantial and burgeoning infrastructure to
support the acceleration of future product development and expansion
- Synergies from being Vertically Integrated: Having branded stores, cannabis dispensing stores, and owned production
facilities ensures a vertically integrated company that can best drive greater margins in the wholesale and retail markets of
the new cannabis sector"
Organigram Holdings Inc. (OTCQB: OGRMF) is a leading licensed producer of medical marijuana based in Moncton, New Brunswick. Recently, the company announce the yield results from the inaugural harvest in the
first of its 23 new, state-of-the-art Phase 2 indoor grow rooms. Beginning on Friday, "4/20" and completed on Saturday,
Organigram harvested over 1500 plants from the first room commissioned in the Company's Phase 2 expansion. The first of the 23
new rooms, which began housing plants on February 10th, has reached final stages of flowering for
its first crops. Harvests from subsequent rooms will begin this week. Initial yields support the Company's predictions that
changes in process efficiencies will result in annual yields higher than initially estimated when Phase 2 was designed. At
present, the Company reaffirms its target production capacity from Phases 1 and 2 of approximately 22,000 kg/year (up from
initial estimations of 16,000 kg/year). Facility enhancements include a fully-automated irrigation system, automated potting, a
fully automated waste destruction system and automated packaging lines, adding to a data-based production approach which ensures
growing optimization for every room.
Supreme Cannabis Company, Inc. (OTC: SPRWF) is a Canadian publicly traded company committed to becoming a leading
cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed
producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Facility. The Hybrid Facility
combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single
large-format production footprint. In March, the company announced that it has entered into a definitive agreement pursuant to
which Supreme Cannabis will complete a C$10,000,000 strategic equity investment in Medigrow. Upon
completion of the Investment, Supreme Cannabis will hold an approximate 10% ownership interest in Medigrow. Supreme Cannabis
expects strong demand to exceed supply for medical cannabis oil globally and believes Lesotho is
well suited to produce quality cannabis oil and Medigrow possesses the expertise to meet the highest quality standards.
THC BioMed Intl Ltd. (OTCQB: THCBF) is an ACMPR Licensed Producer and a supplier of legal Cannabis Genetics. THC also
produces and sells dried and fresh marijuana and cannabis oil for medical purposes. THC is also active in scientific research and
the development of products and services related to the medical cannabis industry. Earlier this month, the company announced that
it will purchase a building in downtown Kelowna. The building consists of two stories and has
8000 sq. feet of space. The building is one of very few buildings based in the downtown Kelowna
that is zoned for industrial use. The city of Kelowna permits cannabis production on
industrial-zoned land. The purchase price is $1,875,000, plus fees and taxes, for a total of
$1,922,273. THC is purchasing the property for cash and will not require a mortgage.
iAnthus Capital Holdings, Inc. (OTCQB: ITHUF) owns and operates best-in-class licensed cannabis cultivation, processing
and dispensary facilities throughout the United States. Recently, the company announced the
completion of its acquisition of the remaining 20% of Pilgrim Rock Management, LLC, the affiliated management and services
company that provides intellectual property licensing, professional and management services, real estate and equipment leasing,
and certain other services to Mayflower Medicinals, Inc. ("Mayflower"). Mayflower, a non-profit Massachusetts corporation affiliated with Pilgrim Rock, has received two provisional licenses to operate
Registered Marijuana Dispensaries ("RMDs") in Massachusetts, with a third RMD application
pending before the Massachusetts Department of Public Health ("DPH"). Following the acquisition, iAnthus now owns 100% of Pilgrim
Rock.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For weedmd inc. financial news dissemination and PR services, FinancialBuzz.com has
been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or
negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are
commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of
the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR
advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post
information about any companies the information contained herein is not intended to be used as the basis for investment decisions
and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or
solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or
losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or
presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their
investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and
financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by
the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives,
other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and
legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless
of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please
visit: http://www.financialbuzz.com.
Media Contact:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com